Evaluating predictors of renal injury with sorafenib in hepatocellular carcinoma: A multi-ethnic cohort study

MLA

Li Zhang, et al. “Evaluating Predictors of Renal Injury with Sorafenib in Hepatocellular Carcinoma: A Multi-Ethnic Cohort Study.” Journal of Onco-Nephrology, vol. 5, Apr. 2021, pp. 89–95. EBSCOhost, https://doi.org/10.1177/23993693211009238.

APA

Li Zhang, Hala T. Borno, Kelsey Natsuhara, & Christopher A. Carlos. (2021). Evaluating predictors of renal injury with sorafenib in hepatocellular carcinoma: A multi-ethnic cohort study. Journal of Onco-Nephrology, 5, 89–95. https://doi.org/10.1177/23993693211009238

Chicago

Li Zhang, Hala T. Borno, Kelsey Natsuhara, and Christopher A. Carlos. 2021. “Evaluating Predictors of Renal Injury with Sorafenib in Hepatocellular Carcinoma: A Multi-Ethnic Cohort Study.” Journal of Onco-Nephrology 5 (April): 89–95. doi:10.1177/23993693211009238.